Lee Pyng is Professor, Yong Loo Lin School of Medicine, National University of Singapore. She is also Director of Interventional Pulmonology, Division of Respiratory and Critical Care Medicine, National University Hospital. Professor Lee has an active interest in lung cancer, pleural disease, obstructive airway disease, bronchoscopy and pleuroscopy. She was the past President of Singapore Thoracic Society, and serves on international scientific committees in Lung Cancer, Bronchology and Interventional Pulmonology as well as American College of Chest Physician Steering Committees. She represents Singapore as Global Governor for American College of Chest Physicians and is invited locally and overseas to speak and instruct in pleuroscopy, bronchoscopy, bronchial thermoplasty and lung cancer. Professor Lee is the author of publications in peer-reviewed journals, has written a manual and a book on pleuroscopy that worn the British Medical Association Best Book Award in internal medicine in 2011. She received the Young Investigator’s award 2000 for work in asthma, Best Poster Award for research in talc and cancer cells at CHEST 2006, Best Original Investigation and Presentation at Chest World Congress 2014, and the Geoffrey McLennan Award for advancing the field of Interventional Pulmonology at CHEST 2014, Austin, Texas. In 2018, she was conferred AC Shah Oration Award for Woman Researcher in Interventional Pulmonology by Indian Association for Bronchology. She has completed her PhD on New Applications of Bronchoscopic Techniques conferred by Vrije University, Amsterdam in 2014, first in Respiratory medicine She also received Best Teacher Award in 2012 for undergraduate education, National University Hospital teaching excellence award for post-graduate education in 2014, and the prestigious Outstanding Tutor Award by National University of Singapore Medical Society. She is recently conferred the prestigious Pasquale Ciaglia award by CHEST 2019 for interventional medicine.

Dr. Musani serves as the chair of the Interventional Pulmonology Institute and the Financial Affairs and Fundraising Committee of the World Association for Bronchology and Interventional Pulmonology (WABIP). He is the former President and currently chair of the Regulatory and Advocacy Committee of the American Association for Bronchology and Interventional Pulmonology (AABIP). Dr. Musani has always been a loyal servant in the field of Interventional Pulmonology around the globe. As an expert in the field of IP, he serves the advisory, editorial, and scientific boards of numerous national and international organizations. He has authored several books on IP-related subjects and edited several pulmonary and IP journals over the years. Throughout his career, Dr. Musani has authored hundreds of scientific publications, book chapters, editorials, abstracts, case reports, and scientific reviews. He has been writing the scientific corner of the WABIP Newsletter since its inception. Dr. Musani recently received the 2022 Distinguished Educator Award from the American College of Chest Physicians and the 2022 Distinguished Service Award from the AABIP. Throughout his career, his passion and goals for the field have always laid in the democratization of medicine and the elevation of health education and health delivery standards in resource-poor areas of the world.

Stefano Gasparini, MD graduated from the University of Ancona in 1978. He subsequently specialized in Pulmonary Diseases (1982), Respiratory physiology (1985), and Anesthesiology/Intensive Care Medicine (1990) at the University of Ancona and University of Naples, Italy. He was Director of the Pulmonary Diseases Unit of the Hospital of Ancona since June, 2000 up to 2019. He was named Associate Professor of Respiratory Medicine at the Università Politecnica delle Marche Medical School in 2012 and Full Professor in 2019.

He is Director of Specialty School in Respiratory Medicine and Director of the Postgraduate Master in Interventional Pulmonology at the University of Ancona. He has authored or coauthored more than 250 peer-reviewed scientific publications, is regularly invited to teach and lecture around the globe, and has prestigious leadership positions in several international medical societies and medical journals. Prof. Gasparini was WCBIP President of the 19th World Congress of Bronchology and Interventional Pulmonology held in Florence, Italy in 2016 and recipient of the Gustav Killian award by WABIP in 2018.

Dr. Khemasuwan earned his MD from Chulalongkorn University in Thailand and later completed an MBA in Healthcare Management at Temple University in Philadelphia, Pennsylvania, USA. His extensive training includes fellowships in pulmonary and critical care medicine at the Cleveland Clinic and advanced interventional pulmonary training at Henry Ford Hospital. Currently, Dr. Khemasuwan is an Associate Professor at Virginia Commonwealth University (VCU) Medical Center in Richmond, USA, where he also serves as the Director of the Interventional Pulmonary Fellowship Program. His research interests encompass advanced diagnostic and therapeutic bronchoscopy, the application of artificial intelligence in pulmonary medicine, and healthcare management. Dr. Khemasuwan has actively contributed to multiple committees within the American Association for Bronchology and Interventional Pulmonology (AABIP) and the American Thoracic Society (ATS). He is honored to serve as the Chair of the Finance Committee for WABIP.

Dr Hind janah, MD, is a pulmonologist and allergist specialized in interventional pulmonology and rare lung diseases. She is the founder and president of the Moroccan association of interventional pulmonology (AMPI). Dr. Janah’s key interests reside in advancing practices in interventional pulmonary in Morocco and is the person behind the 2024 first international conference of interventional pulmonology in Morocco . She is currently one the first IP experts in interventional pulmonology in Morocco. She is highly engaged in leading interventional workshops,masterclasses and conferences on advanced pulmonary techniques. She is a member of Assembly 11: thoracic oncology in European respiratory society and participates in the lung cancer diagnosis Group for drafting recommandations regarding Lung Cancer management in Morocco the aegis of the lalla salma Foundation for oncology . Among her objectives is to enable access to interventional pulmonary expertise across as many countries as possible in the MENA region and beyond.

Her key qualifications include DIU in respiratory home ventilation from Sorbone University, DIU chronic pulmonary vascular diseases from Paris -Ssaclay University. She graduated from University Hassan II, Casablanca, Morocco.

Aleš Rozman graduated from the Faculty of Medicine, University of Ljubljana, in 2000. He later specialized in pulmonology (2007) and completed postgraduate training in medical oncology (2008). In 2017, he earned his PhD from the University of Ljubljana’s Faculty of Medicine and, in 2018, completed postgraduate studies in Health management and leadership competencies at the same University. That same year, he was appointed Associate Professor at the Faculty of Medicine, University of Ljubljana.

Dr. Rozman has been active in interventional pulmonology since 2002 and has led the Department of Endoscopy at the University Clinic Golnik since 2010. Between 2018 and 2022, he also served as the General Director of the University Clinic Golnik. In 2024, he was elected Chair of Group 14.1 for Interventional Pulmonology at the European Respiratory Society (ERS).

An accomplished author, Dr. Rozman has contributed to numerous publications and organized a wide range of educational events, conferences, and workshops. Since 2018, he has been a faculty member of the European School for EBUS. He has received several national and international awards for his work in interventional pulmonology and, in 2024, was appointed Visiting Professor at the Faculty of Medicine in Belgrade (Serbia). Additionally, he has served two terms as the Chair of the Health Council of the Republic of Slovenia.

Dr. Naofumi Shinagawa graduated from Asahikawa medical University in 1996. After taking his residency in KKR Sapporo Medical Centre, and some hospitals in Hokkaido, Dr. Shinagawa engaged in academic clinical research works at Hokkaido University Hospital. He studied respiratory intervention including rigid bronchoscope at Heidelberg University Thoraxklinik in 2007 from Dr. H. Becker, Dr. R. Eberhardt, and F. Herth. As Lecturer of the Department of Respiratory Medicine at First Department of Medicine, Hokkaido University Hospital since 2015. Dr. Shinagawa’s focus is on clinical research on pulmonary intervention and cancer chemotherapy. Dr. Shinagawa received the Japanese pulmonary intervention award in 2019. His main targets are diagnostic approach to the peripheral lung lesions using navigation system, and pulmonary intervention. Many publications prove his efforts and creativity in this field. He is honoured to be a part of steering committee of this Society.

Dr. Kazuhiro Yasufuku is Professor of Surgery at the University of Toronto, Staff Thoracic Surgeon at the Division of Thoracic Surgery at Toronto General Hospital. He is the Director of the Interventional Thoracic Surgery Program at the University Health Network (UHN), which includes the Interventional Thoracic Surgery Animal Operating Room capable of high-end endoscopic development and the state-of-the-art Interventional Thoracic Surgery Suite at the Toronto General Hospital for clinical application of new developments. He has continued to improve the quality and capability of minimally invasive diagnostics and reduced the timeline of detection, diagnosis and treatment of lung cancer.

Dr. Yasufuku is very active in International Societies related to Thoracic Surgery and Interventional Pulmonology. In addition to his roles as WABIP Newsletter Editor-in-Chief and Executive Board member, he serves as the Vice Chair of the Interventional Chest/Diagnostics Procedure Network Committee for CHEST, Secretary General of the Asian-Pacific Association for Bronchology and Interventional Pulmonology. He is also Associate Editor for the Journal of Bronchology and Interventional Pulmonology and Associate Editor for Respiration. He is actively involved in innovation and currently a member of the AATS/STS (American Association for Thoracic Surgery/Society of Thoracic Surgeons) Workforce on New Technology.